A pigment-focused prescription to discuss after identifying the cause of a dark patch. Its ingredient list is more relevant to discoloration than to general moisturization, and the plan should include reassessment rather than indefinite unsupervised use.
- Key formulation
- Hydroquinone, kojic acid and niacinamide
- Product type
- Prescription compounded topical
- Price checked October 8, 2026
- Confirm current price
- Medical review
- No independent medical review claimed
What stands out
- Clearly focused on a pigment concern
- Three named ingredients in the public catalog
What to weigh
- Needs a diagnosis and treatment-duration discussion
- Patient-specific strength is not established by the catalog
What is in the formula?
The provider catalog lists hydroquinone, kojic acid and niacinamide in Spot On. It positions the cream for dark spots, sun spots and post-acne marks. Those labels describe a range of concerns; they do not establish that every visible spot should be treated with the same product.[source]
How strong is the evidence?
The main review question is whether the exact formula and intended duration suit a diagnosed pigment problem. We did not verify a finished-product trial demonstrating how much discoloration this particular blend reduces or how it compares with Agency Dark Spot. A marketing goal is not a measured outcome.[source]
Compounded drugs are not reviewed by FDA for safety, effectiveness or quality before they are marketed. That does not mean every compounded prescription is inappropriate; it means the consultation and pharmacy information matter, and approved-product evidence should not be silently transferred to this formula.[source]
What it means for your routine
A targeted pigment product may make more sense than adding several separate brightening serums. Combining active ingredients can also complicate the search for an irritation trigger. Ask what should remain in the routine, what should pause and when the clinician expects to reassess progress.
Questions to raise with your prescriber
A new, changing, bleeding or otherwise concerning lesion needs assessment before cosmetic fading. Contact the clinician about irritation or unexpected worsening. Sun protection matters in a pigment-management routine, but no cream is a substitute for evaluating an uncertain diagnosis.
What to check in the price
CoreAge Rx’s catalog does not establish a universal standalone Spot On price. Confirm whether the consultation, cream, shipping and subsequent reviews are included in the quote. Ask about refund rules before paying a consultation charge.[source]
How to compare the alternatives
Compare the prescribed hydroquinone concentration, the non-active base and the monitoring plan with Agency Dark Spot. If a formula is hydroquinone-free, it is a different comparison; do not assume two products with “spot” in the name contain the same treatment.
See the full brand review for the care model, and compare the other product reviews before making a treatment decision.
Your questions, answered
Is this an FDA-approved finished product?
This review covers a compounded prescription formula. FDA does not approve compounded drugs as finished products. Ask the prescriber to explain why the specific preparation is appropriate.
Did you test the cream?
No. This is an analysis of current provider information and cited clinical or regulatory guidance. We did not buy, apply or laboratory-test the product.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center — What products does CoreAge Rx offer?Provider catalog, updated October 5, 2026; formulations and consultation terms
- American Academy of Dermatology — Skin care in your 40s and 50sPractical skin-care foundations for mature skin
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations